Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › DLL3 targeting chimeric antigen receptors and binding agents

DLL3 targeting chimeric antigen receptors and binding agents

US Patent 11673953 · Granted Jun 13, 2023

Estimated economic value: $11,194,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Protease-activating CD45-gate CAR2025
Chimeric antigen receptors targeting FLT32025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Anti-coronavirus antibodies and methods of use2024
Methods of manufacturing allogeneic CAR T cells2024
Inducible chimeric cytokine receptors2024